Cytokine Contribution to the Repair Processes and Homeostasis Recovery following Anoxic Insult: A Possible IFIM-γ-Regulating Role in IL-1βNeurotoxic Action in Physiological or Damaged CNS

NeuroImmunoModulation

Volumn 3, Issue 4, 1996, Pages 213-218

  Pellegrini, Patrizia ^a   Berghella, Anna Maria ^a   Di Loreto, Silvia ^a   Del Beato, Tiziana ^a   Di Marco, Franca ^a   Adorno, Domenico ^a   Casciani, Carlo Umberto ^a  

^a CNR Inst Tissue Typing Dialysis   (Italy)

Author keywords

Anoxia; Cytokines; Gamma interferon; Interleukin 1 neurotoxicity; Neuroimmunomodulatory network

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; GAMMA INTERFERON; INTERLEUKIN 1;

ANIMAL TISSUE; ANOXIA; ARTICLE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; EMBRYO; HIPPOCAMPUS; HOMEOSTASIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANOXIA; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; HOMEOSTASIS; INTERFERON TYPE II; INTERLEUKIN-1; RATS;

EID: 12644280865     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097273     Document Type: Article

References (50)

1. Thomson A: The Cytokine Handbook, cd 2, London, Academic Press, 1994.
2. D'Andrca AD, Fasman GD, Lodish HF: Erythropoietin receptor and interleukin-2 receptor 5 chain: A new receptor family, Cell 1989:58: 1023-1024.
3. Gearing DP, King JA, Gough NM, Micola NA: Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor, EMBO J 1989:8:3667-3676.
4. Sei Y, Vitkovic L, Yokoyama MM: Cytokines in the central nervous system: Regulatory roles in neuronal function, cell death and repair, Neuroimmunomodulation 1995:2:121-133.
5. Wong M-L, Bongiomo PB, Gold PW, Licinio J: Localization of interleukin-1 convening enzyme mRNA in rat brain vasculature: Evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels, Pathophysiological implications, Neuroimmunomodulation 1995:2:141 -148.
6. Di Santo E, Sironi M, Pozzi P, Gnocchi P, Isct-ta AM, Delvaux A, Goldman M, Marchant A, Ghezzi P: Interleukin-10 inhibits lipopolysac-charide-induced tumor necrosis factor and interleukin- Ip production in the brain without affecting the activation of the hypothalamus-pituitary-adrcnal axis, Neuroimmunomodulation 1995:2:149-154.
7. Kageyama K, Watanobe H, Takebe K: In vivo evidence that arginine vasopressin is involved in the adrenocorticotropin response induced by interleukin-6 but not by tumor necrosis factor-a in the rat, Neuroimmunomodulation 1995:2: 137-140.
8. Dc Sarro G, Rotiroti D, Audino MG, Graticri S, Nistico G: Effects of interleukin-2 on various models of experimental epilepsy in DBA/2 mice, Neuroimmunomodulation 1994:1:361-369.
9. Zuo YC, Li YF, Mei L, Fan SG, Ding GF: Brain interleukin-1 is involved in generation of the serum suppressive factor induced by restraint stress in mice, Neuroimmunomodulation 1995:2:82-87.
10. Karanth S, Lvson K, McCann SM: Cyclosporin A inhibits interlcukin-2-induccd release of corticotropin-releasing hormone, Neuroimmuno-modulation 1994:1:82-85.
11. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibit is neuronal damage induced by cerebral ischemia or NMDA-rcccptor activation in the rat, Brain Res Bull 1992:585:135-160.
12. Brenncman DE, Schultzber M, Bartfai T, Gozcs I: Cytokine regulation of neuronal survival, J Neuroehcm 1992:58:454-460.
13. Awaitsuji H, Furukawa Y, Nakajima M, Furu-kawa S, Haysahi K: Interleukin-2 as a ncuro-trophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain, J Neurosci Res 1993:35:305-311.
14. Sivron T, Ilirschberg DL, Jeserich G, Schwartz M: Soluble factor(s) produced in injured fish optic nerve regulate the postinjury number of oligodendrocytes: Possible role of macrophages, Glia 1991:4:591-601.
15. Eitan S, Schwartz M: A transglutaminase that converts interleukin 2 to a factor cytotoxic to oligodendrocytes, Sciencc 1993:261:106-108.
16. Frei K, Malipicro UV, Leist TP, Zinkernagel RN, Schwab ME, Fontana A: On the ccllular source and function of interleukin-6 produced in the central nervous system in viral disease, EurJ Immunol 1989:19:689-694.
17. Sporn MB, Roberts AB: Peptide growth factors are multifunctional, Nature 1988:332:217-219.
18. Abbas AK, Williams ME, Burstein HJ, Chang T-L, Bossu P, Lichtman AH: Activation and functions of CD4+ T-ccll subsets, Immunol Rev 1991:123:5-22.
19. Baudry M, Bundman MC, Smith EK, Lynch GS: Micromolar calcium stimulates proteolysis and glutamate binding in rat brain synaptic membranes, Science 1981:212:937-938.
20. Färber JL, Chien KR, Miltnachl S: The pathogenesis of irreversible cell injury in ischemia, Am J Pahol 1981;102:271-281.
21. Gilbert DS, Newby BJ, Anderton BH: Neurofilament disguise, destruction, and discipline, Nature 1975;256:586-589.
22. Watkins JC: Excitatory amino acids; in McGeer EG, Olney JW, McGeer PL (eds): Kainic Acid as a Tool in Neurobiology, New York, Raven Press, 1978.
23. CofTman RL, Varkila K, Scott P, Chatelain R: Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo, Immunol Rev 1991;123:189-207.
24. Romagnani S: Induction of TH1 and TH2 responses: A key role for the 'natural’ immune response? Immunol Today 1992:13:379-381.
25. Pellegrini P, Berghella AM, Del Beato T, Cicia S, Adomo D, Casciani CU: Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression, Cancer Immunol Immunothcr 1996;42:1-8.
26. Pellegrini P, Berghella AM, Del Beato T, Adorno D, Casciani CU: Immunological directives for biotherapy improvement in the treatment of colorectal cancer patients, Cancer Biother Radiopharm 1996; 11:113-118.
27. Chao CC, Molitor TW, Hu S; Neuroprotective role of IL-4 against activated microglia, J Immunol 1993;151:1473-1481.
28. Suzumura A, Sawada M, Hoh Y, Marunouchi T: Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression, J Neuroimmunol 1994;53:209-218.
29. Muegge K, Williams TM, Kant J, Karin M, Chiu R, Schmidt A, Siebcnlist U, Young HA, Durum SK: Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1, Science 1989;246:249-251.
30. Takaya S, Masato N, Atsushi M, Yoshito K: Involvement of ras p21 protein in signal transduction pathways from interleukin 2, interleukin 3, and granulocyte-macrophage colony-stimulating factor, but not from interleukin 4, Proc Natl Acad Sei USA 1991;88:3314-3318.
31. Araujo DM, Lapchak PA, Collier B, Quirion R: Localization of interleukin-2 immunoreactivi-ty and interleukin-2 receptors in the rat brain: Interaction with the cholinergic system, Brain Res 1989;498:257-266.
32. Lapchak PA, Araujo DM, Quirion R, Beaudet A: Immunoautoradiographic localization of in-terleukin-2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain, Neuroscience 1991; 44:173-184.
33. Teti G, Mancuso G, Tomasello F: Cytokine appearance and effects on anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection, Infect Im-mun 1993;61:227-235.
34. Berghella AM, Pellegrini P, Piancatelli D, Mac-carone D, Del Beato T, Giubilei D, Pomidori A, Adomo D, Casciani CU: Progression mechanisms in colon cancer: sIL-2R, IL-2 + anti-CD3 proliferative response and tumour stage correlations, Cancer Immunol Immunother 1994:38:160-166.
35. Spranger M, Lindholm D, Bandtlow C, Heu-mann G, Naher-Noe M, Thoenen H: Regulation of nerve growth factor (NFG) synthesis in rat central nervous system: Comparison between the effects of interleukin-1 and various growth factors in astrocyte culture and in vivo, EurJNcurosci 1990;2:69-76.
36. Miller LG, Galpem WR, Dunlap K, Dinarello CA, Turner TJ: Interleukin-1 augments y-ami-nobutyric acid,\ receptor function in brain, Mol Pharmacol 1990;39:105-108.
37. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M: Convulsants induce inter-leukin-lp messenger RNA in rat brain, Bio-chem Biophys Res Commun 1990:171:832-837.
38. Minami M, Kuraishi Y, Yabuuchi K, Yamaza-ki A, Satoh M: Induction of interleukin-ip in rat brain after transient forebrain ischemia, J Neurochem 1992;58:390-392.
39. Benveniste EN, Sparacio SM, Norris JG, Gre-nett HE, Fuller GM: Induction and regulation of interleukin-6 gene expression in rat astrocytes, J Neuroimmunol 1990;30:201-212.
40. Bethea JR, Chung IY, Sparacio SM, Gillespie GY, Benveniste EN: Interleukin-1 beta induction of tumor necrosis factor-alpha gene expression in human aslroglioma cells, J Neuroimmunol 1992;36:179-191.
41. Legoux P, Minty C, Delpech B, Minty AJ, Shire D: Simultaneous quantitation of cytokine mRNAs in interleukin 1 p-stimulated U373 human astrocytoma cells by a polymerase chain reaction method involving coamplification with an internal multispecific control, Eur Cytokine Network 1992;3:553-563.
42. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C: Production of hemolymphopoietic cytokine (IL-6, 1L-8, colony-stimulating factors) by normal human astrocytes in response to IL-ip and tumor necrosis factor a, J Immunol 1992;149:2358-2366.
43. McAveney KM, Gomella LG, Lattime EC: Induction ofTHl- and TH2- associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy, Cancer Immunol Immunother 1994;39:401-406.
44. Brinkman V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells, J Exp Med 1993; 178:1655-1661.
45. Werner ER, Wemer-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H: Parallel induction of tetrahydrofobioprotein biosynthesis and indoleamine-2,3-dioxygenase activity in human cells and cell lines by y-interferon, BiochcmJ 1989;262:861-866.
46. Saito K, Chen CY, Masana M, Crowley JS, Markey SP, Hcyes MP: 4-Chloro-3-hydroxyan-thranilate, 6-chlorotryptophan and norhar-mane attenuate quinolic acid formation by in-terferon-y-stimulated monocytes (THP-1 cells), Biochem J 1993;291:11-14.
47. Schwarcz R, Okuno E, White RJ, Bird ED, Whetsell WO: 3-Hydroxyanthranilic acid oxygenase activity is increased in the brains of Huntington disease victims, Proc Natl Acad SciUSA 1988;85:164-169.
48. Moroni F, Lombardi G, Carla V, Etienne P, Nair NFV: Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure, J Neurochem 1986;47:1667-1671.
49. Heyea MP, Rubinow D, Lane C, Markey SP: Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome, Ann Neurol 1989;26:275-277.
50. Meldrum B, Garthwaite J: Excitatory amino acid neurotoxicity and neurodegenerative disease, TiPS Special Report 1991;165:54-61.